If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
245.00    11.00 (4.78%)
Bid:
237.00
Ask:
245.00
Spread: 8.00 (3.376%)
Market Cap: £27.28m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

TVL and E3 Lithium Refining Partnership

Today 14:20

RNS Number : 5698L
Alkemy Capital Investments PLC
08 July 2026
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 ("MAR") AS IN FORCE IN THE UNITED KINGDOM PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

8 July 2026

Alkemy Capital Investments Plc

 

TVL and E3 Lithium Refining Partnership

 

Alkemy Capital Investments plc ("Alkemy") (LSE: ALK), the 100% owner of Tees Valley Lithium Ltd ("TVL") is pleased to announce that TVL has entered into a non-binding Heads of Terms with E3 Lithium Ltd. ("E3"), a Canadian lithium development company, setting out the commercial framework for a proposed long-term refining partnership.

The Heads of Terms sets out the framework under which E3 would utilise TVL's UK lithium hydroxide conversion capacity in the UK to convert lithium carbonate from its Clearwater Project in Alberta, Canada into battery-grade lithium hydroxide for supply to E3's customers.

The proposed arrangement would provide E3 with access to a Lithium Hydroxide supply chain to diversify both the geographical reach and the lithium chemistries available to it's customers, while further demonstrating demand for TVL's independent merchant refining model.

Highlights

· Non-binding Heads of Terms signed for a refining partnership

· Up to 50,000t over an initial 10-year term

· Provides E3 access to supply battery-grade lithium hydroxide into the high growth European market via TVL's UK refinery.

 

Strategic significance

The proposed partnership gives commercial effect to the deepening cooperation among allied nations on critical minerals, from the UK-Canada critical minerals cooperation agreement signed in 2023 to the G7 Critical Minerals Action Plan launched in Alberta in June 2025. By anchoring lithium conversion capacity in the UK, the partnership supports the UK Critical Minerals Strategy's ambition to grow domestic processing capability and reinforces TVL's position as an independent merchant lithium refiner at the heart of a resilient transatlantic supply chain.

The Heads of Terms builds on TVL's previously announced binding offtake agreement with a wholly owned subsidiary of Glencore plc for up to 10,000 tonnes per annum of battery-grade lithium hydroxide and supports TVL's strategy of a diversified customer base.

 

Sir Chris Bryant, MP and UK Minister of State at the Department for Business and Trade, commented:

"We need critical minerals for everything, from the phones we use to the cars we drive, and this agreement brings to life our thriving critical minerals collaboration with Canada which will help boost domestic production, drive economic growth and build more resilient supply chains.

This is our Critical Minerals Strategy in action: forming dynamic relationships with partners across the world to boost our economic security and helping build more sustainable and diversified supply chains for critical minerals."

Vikki Jeckell, CEO of Tees Valley Lithium, commented:

"This refining partnership with E3 Lithium marks another important step in demonstrating the demand for Tees Valley Lithium's independent merchant refining model alongside our previously announced binding offtake agreement with Glencore."

Chris Doornbos, CEO and Chair of E3 Lithium, commented:

"This agreement gives E3 meaningful optionality as we negotiate with potential offtake partners. This framework provides a potential pathway to serve hydroxide demand while we continuing to focus on our speed to market and enhanced capital efficiencies for our carbonate production. We look forward to our ongoing collaboration with TVL."

 

About E3 Lithium Ltd.

E3 Lithium is a lithium development company with a total of 21.2 million tonnes (Mt) of lithium carbonate equivalent (LCE) Measured and Indicated as well as 0.3 Mt LCE Inferred mineral resources in Alberta, Canada. The Clearwater Pre-Feasibility Study outlined a 1.13 Mt LCE proven and probable mineral reserve with a pre-tax NPV(8%) of USD 5.2 Billion with a 29.2% IRR and an after-tax NPV(8%) of USD 3.7 Billion with a 24.6% IRR.  

 

Further information

 

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk.

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

Zeus Capital

Tel: 0203 829 5000

 

ABOUT US

 

Alkemy Capital Investments plc: Alkemy is focused on the development of critical mineral infrastructure to support the global energy transition. Through its wholly owned subsidiary, TVL, Alkemy is leading the way in establishing Europe's first independent lithium hydroxide refinery.

 

Tees Valley Lithium Limited: is building a £185 million merchant lithium refinery in the Billingham chemical cluster Teesside which will refine high value domestic and international feedstock into 25,000 tonnes per year of battery-grade lithium using Veolia's commercially validated process technology - enough to support the production of 550,000 electrical vehicles.

 

Forward Looking Statements

 

This news release contains forward‐looking information. The statements are based on reasonable assumptions and expectations of management and Alkemy provides no assurance that actual events will meet management's expectations. In certain cases, forward‐looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Alkemy believes the expectations expressed in such forward‐looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. In addition, factors that could cause actual events to differ materially from the forward-looking information stated herein include changes in market conditions, changes in metal prices, general economic and political conditions, environmental risks, and community and non-governmental actions. Such factors will also affect whether Alkemy will ultimately receive the benefits anticipated pursuant to relevant agreements. This list is not exhaustive of the factors that may affect any of the forward‐looking statements. These and other factors should be considered carefully and readers should not place undue reliance on forward-looking information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADXPEFPKEFA
Date   Source Headline
29th May 20127:00 amRNSTrading Statement
14th May 20129:59 amRNSHolding(s) in Company
10th May 20129:20 amRNSTotal Voting Rights
8th May 201210:15 amRNSHolding(s) in Company
3rd May 20128:00 amRNSIssue of Equity
2nd May 201212:39 pmRNSDirector/PDMR Shareholding
30th Apr 201210:22 amRNSNotice of AGM
27th Apr 20127:00 amRNSCompletion of Acquisition of Greenpark Energy Ltd
25th Apr 20129:40 amRNSBiogas and North East Wales AD Project Update
25th Apr 20127:00 amRNSre Update on Projects
7th Mar 20127:00 amRNSPreliminary Results
2nd Feb 20127:00 amRNSAcquisition and Trading Update
22nd Dec 20117:00 amRNSAppointment of Broker
20th Sep 20117:00 amRNSNew banking facility
15th Sep 20114:36 pmRNSDirector/PDMR Shareholding - Replacement
15th Sep 20112:44 pmRNSHolding(s) in Company
7th Sep 20117:00 amRNSInterim Results
31st Aug 20119:00 amRNSALKANE & TEG AWARDED BIDDER STATUS FOR AD PLANT
11th Aug 20119:00 amRNSNotice of Results
15th Jul 20114:00 pmRNSAdditional Listing
10th Jun 20117:00 amRNSDECC Licence Approval for Seven Star Acquisition
27th May 20115:19 pmRNSHolding(s) in Company
27th May 201111:27 amRNSTotal Voting Rights
26th May 201110:58 amRNSDirector/PDMR Shareholding
26th May 201110:35 amRNSAcquisition and Fundraising
13th May 201111:54 amRNSHolding(s) in Company
4th May 20112:24 pmRNSResults of AGM
4th May 20117:00 amRNSAGM Statement and Trading Update
12th Apr 201111:06 amRNSAnnual Financial Report
6th Apr 20113:51 pmRNSDirector/PDMR Shareholding
9th Mar 20117:00 amRNSPreliminary Results
11th Jan 20117:00 amRNSNotice of Results and Trading Update
11th Nov 201011:48 amRNSHolding(s) in Company
20th Oct 20103:27 pmRNSAdditional Listing
20th Oct 20103:27 pmRNSAdditional Listing
8th Oct 20101:50 pmRNSDirector/PDMR Shareholding
8th Oct 20101:48 pmRNSAdditional Listing
30th Sep 201012:02 pmRNSAdditional Listing
30th Sep 201012:01 pmRNSAdditional Listing
30th Sep 201012:00 pmRNSTotal Voting Rights
16th Sep 201012:18 pmRNSAdditional Listing
8th Sep 20107:00 amRNSInterim Results
3rd Sep 20107:00 amRNSAlkane Extends Tolling Agreement with GDF SUEZ
24th Aug 201010:16 amRNSNotice of Results
7th Jul 20107:00 amRNSTrading Statement
6th May 20107:00 amRNSGrant of Options
28th Apr 20102:28 pmRNSResult of AGM
28th Apr 20107:00 amRNSTrading Statement
13th Apr 20103:06 pmRNSAnnual Report and Accounts
11th Mar 201011:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.